Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-04

Clinical Trial Update: Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of GSK256073A in healthy volunteers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK256073A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Dyslipidaemias | Phase 1 | Status: COMPLETED